Hand and foot PUVA (Psoralen + ultra violet light - wavelength A)

Similar documents
PUVA (Psoralen + ultra violet light - wavelength A)

PUVA (Psoralen + ultra violet light - wavelength A)

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

Whole body PUVA treatment. Information for patients Dermatology

Psoralen Tablets (Methoxypsoralen)

Treating your skin condition with Broadband ultraviolet B radiation (BB-UVB)

Narrow Band (TL-01) Treatment. Under review

TL-01 phototherapy treatment. Information for patients Dermatology

Ultra Violet Treatment PUVA

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

Total Skin Electron Beam Therapy (TSEBT)

INFORMATION NOTE No 354: SUNBED REGULATION ACT 2010

Eumovate Ointment clobetasone butyrate

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

Dermovate Ointment clobetasol propionate

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

Dermovate Ointment clobetasol propionate

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

Radiotherapy to the skin

Care of your skin. Introduction. What can you do to help? Step 1 - Hygiene. Patient Information

Dermovate Scalp Application clobetasol propionate

Consultation Form: Coffeeberry Peel

Dermovate Scalp Application clobetasol propionate

ISOTREX GEL Isotretinoin 0.05% w/w

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

This pamphlet will give you information about what to expect while receiving radiation therapy for tumours in the brain and the spinal cord area.

HAND DERMATITIS - HOW TO CARE FOR YOUR HANDS

Radiotherapy to the breast. Information and advice for patients, relatives and carers

Forename Surname... SOPRANO ICE SHR LASER CONSULTATION FORM

1 What Gyno-Daktarin cream is and what it is used for

Eumovate Cream clobetasone butyrate

SIGMACORT cream and ointment

Patient Information Leaflet. Dermal Filler

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Melasma can run in families, suggesting an inherited tendency.

Laser Resurfacing Post Op

STAY SAFE IN THE SUN. INFORMATION TAKEN FROM THE NHS CHOICES WEBSITE

Dalacin V Cream Clindamycin phosphate

Permanent Makeup Before & Aftercare Instructions. Permanent Makeup by Michelle Louise

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Informed Consent For Facial Rejuvenation/Collagen Remodel

ACCUTANE MAKES ME CRY

Retin-A 0.05% w/w cream

Tattoo fading by Laser

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Advice for patients after removal of a pilonidal sinus

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

You and your scalp. Helpful hints and advice on treating Dry Scaly Scalp Conditions

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

English. Address: Exorex Skincare Centre St Thornhill, Ontario Canada L4J 3M8. Telephone: Fax:

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

Consultation Form: AHA Chemical Peel

Pre and Post Procedure Information for Cosmetic Laser Skin Resurfacing with the DOT laser. James A. Rieger, MD (316)

Patient Instructions for Fractional CO2 Laser Resurfacing

CONSUMER MEDICINE INFORMATION

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Post Treatment Progression

Package Leaflet: Information for the User

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Ultraviolet Radiation

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

1. Wounds may be left exposed with some ointment applied to the stitch line:

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Hair loss. During chemotherapy and radiotherapy. Information for patients Weston Park Hospital

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Patient information. Nipple-areola Tattoo. Breast Services Directorate PIF 1049 V3

5504 Backlick Road Springfield, Virginia

EUMOVATE Clobetasone butyrate 0.05% w/w cream

Self-care information on dry skin

Head and Neck Radiation Treatment Guide

Potassium permanganate

Hair Loss Treatment Regular Strength (Minoxidil)

protect your eyes from UV damage

PROTECT YOUR SKIN YOUR HEALTH AT SEA 3. Merchant Fishing Yachts

Skin Reactions from Radiation Treatments

Skin Care During Radiation Therapy

Potassium permanganate

Products to recommend for the TREATMENT of Dry Eyes

INFORMED CHEMICAL PEEL CONSENT. 1. I authorize the chemical peel listed above, to my face and / or neck, chest and hands.

Living with ichthyosis. A guide to the condition and its management

Soleil Inte Soleil Intensif

EMOLLIENTS. NEW 500g NEW. pump. Up to 37% Wider choice, greater savings! cost savings. without compromising on quality or patient care!

Prior to Toenail Surgery Information Sheet

Daktacort 2% / 1% w/w cream

Information for patients and visitors

Understand wellness, disease prevention, and recognition of symptoms. ESSENTIAL STANDARD - 7. PCH.1

Everything you need to know about TATTOO REMOVAL

Burns Aftercare Guidance. Child Health Patient Information Leaflet

Biobrane TM Dressing. Exceptional healthcare, personally delivered

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

FACT SHEET: ISOTRETINOIN INFORMATION FOR PATIENTS

Lichen Planus. Patient Information. Women and Children Gynaecology

Lichen Planus. Patient Information. Women & Children Gynaecology

NORTH STAR NURSERY AND HOLIDAY CLUB SUN PROTECTION POLICY

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Transcription:

Hand and foot PUVA (Psoralen + ultra violet light - wavelength A)

What is PUVA? Ultra violet light occurs naturally in the sun s rays and is divided into three types - A, B and C - according to its wavelength. Psoralens and sunlight were used by the Egyptians and in India for many hundreds of years to treat skin conditions. Psoralen is a chemical found naturally in more than 30 plants such as parsley, celery and parsnips. It is thought that PUVA works by slowing down the rate of over-production of the skin in patients suffering with psoriasis. The treatment causes slight reddening of the skin and may give you a tan. What conditions can be treated with PUVA? PUVA has been shown to be particularly effective for treating: psoriasis eczema polymorphic light eruptions vitiligo cutaneous T-cell lymphoma. The PUVA machine A small PUVA machine is available for use by patients with hand and foot conditions. This contains many fluorescent tubes and consists of a base unit with a hood. How is treatment given? Your consultant will either prescribe oral PUVA or localised PUVA. Oral PUVA The tablets for UVA may make you feel sick (nauseous), so they should be taken with a light meal and never on an empty stomach. You may find that eating a banana before taking the tablets helps to stop nausea. Once you have taken your tablets you must wear UVA-resistant glasses for 24 hours at all times. This includes indoor use, but excludes bedtime. Your phototherapy nurse will advise you on this. 1

Localised PUVA (hand and foot) Psoralens are also used to treat smaller areas such as the hands or feet. This usually involves soaking the affected areas in a diluted solution of psoralen for 15 minutes. With localised PUVA you will need to thoroughly wash your skin immediately following your treatment. What are the possible side effects? Nausea (oral PUVA only) Itching and dryness of the skin is the main problem. Using soothing moisturisers and anti-histamine tablets can help control this. Redness, burning (and at worst blistering) of the skin may occasionally occur up to 72 hours following treatment, despite our best efforts to avoid this. We aim to minimise your chance of sunburn-like reactions, whilst maximising your chance of a good response to treatment. Damage to the lens of the eye leading to cataracts is possible (oral PUVA only). To minimise this risk we provide protective dark goggles for use during UVA treatment. PUVA has been in use for over 30 years and so far seems to be a safe and effective treatment. It is too soon to be sure about its long-term side effects. After about 200 treatments, it may gradually increase the risk of skin ageing and skin cancer. The skin cancers appear slowly and respond easily to freezing with liquid nitrogen or, in rare cases, removal by minor surgery by your GP or as an outpatient in the Cornwall Dermatology Unit. There is no evidence that Psoralen tablets can affect a developing foetus, but if you think you may be pregnant, stop treatment and inform the staff on the Unit immediately. Past treatment does not affect subsequent pregnancies. What happens when I am referred for treatment? Once your consultant has referred you for treatment, your name is added to our waiting list. You will be contacted either by telephone or letter for your first appointment. You must attend regularly for the treatment to be successful and we ask that you always be on time for your treatment, otherwise we may not be able to treat you. 2

What if I can't attend an appointment? Please telephone and let us know as soon as possible. More than two missed treatments will result in discharge (unless you phone to cancel). Please tell us of any planned holidays so that we can arrange your treatment around this. If you miss more than two weeks in a row we will be unable to continue treatment. How long is a course of treatment? The length of treatment varies, but the average is between 20 to 40 treatments as an outpatient. Trained nurses under medical supervision always administer the treatment. Initial treatment is a low dose, which we gradually increase. The first treatment may be less than a minute, and later treatments as long as 12 minutes. Once your skin is 'clear, your treatment will be stopped or gradually reduced to minimise your number of lifetime treatments. Please note that only patients are allowed in the treatment room. Please do not bring children with you. How do I prepare for treatment? Always tell us of any changes to your medication, as certain medications may make your skin more sensitive to ultra-violet light. You may bathe on the day of treatment, but avoid steroid creams, tar based ointments and greasy emollients. You may apply these one hour after your treatment. Apply cream moisturisers at least one hour before treatment if your skin is dry. Avoid putting any cosmetics, perfumes or aftershave on your skin before treatment as these may increase the sensitivity of your skin. Please ask the staff for advice before using anything. Remove all jewellery before treatment. Minimise sunbathing during your course of treatment (and avoid completely on your days of treatment). 3

What about my glasses or sunglasses? We will check your glasses for UVA resistance. They must be: worn from the moment you swallow the Psoralen tablets until 24 hours later, even on a dull day kept on until bedtime, as even fluorescent lighting can emit UVA light. Remember that UVA light can also penetrate glass. Most prescription spectacles can have a protective coating applied by an optician. During your treatment session You will need to keep your skin covered on the day of treatment. Goggles and visors must be worn at all times. Please bring flip flops/slippers if having foot soaks to wear between machine and soaking area. What should I look out for? If a sunburn-like reaction develops (usually 48-72 hours following treatment), apply plenty of emollient to the affected areas. At your next visit tell us about this reaction before treatment is given. If you develop a more severe reaction, such as peeling, blistering and pain, contact the Dermatology Unit immediately. You may need to come in to see a doctor. Out of hours you will need to go to your nearest Emergency Department. What happens afterwards? When your treatment is completed, we will give you discharge information on what happens next, and how to look after your skin. Further information We are here to provide help and advice. If you have any problems or worries, please contact us on: 01872 255035 or 01872 253265. 4

Patient checklist: Patient information leaflet on hand and foot PUVA treatment discussed. The most common side effect of UVA treatment is burning and itching. Nausea (tablet PUVA only) is less common skin aging. Long term risk of skin cancers increases after 200 exposures. This treatment is not safe during pregnancy. Successful treatment requires regular attendance. Inform the nurse of any new medications. Moisturisers can be applied 1 hour before and 1 hour after treatment. Remove jewellery before treatment. Need to wear eye protection (if oral) for 24 hours post ingestion plus goggles and visor for treatment (check patient glasses). Avoid other sources of UV light during the course of the treatment. Wash hands and feet pior to leaving department. Ensure hands and feet remain covered on the day of treatment. Aware of risks of cold sores (herpes virus). Need to contact the department to report any side effects (contact number given). Need to contact department if unable to attend appointment or discharge. Aware that more than 2 weeks missed treatment will result in discharge. 5

6

If you would like this leaflet in large print, braille, audio version or in another language, please contact the General Office on 01872 252690 RCHT 1726 RCHT Design & Publications 2018 Printed 10/2018 V1 Review due 10/2021